tiprankstipranks
Trending News
More News >
Nabriva Therapeutics (NBRVF)
OTHER OTC:NBRVF
US Market

Compare Nabriva Therapeutics (NBRVF) vs. Competitors

Compare
1,013 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nabriva Therapeutics
$0.01
$323.00
-92.31%
Biodexa Pharmaceuticals
$2.33
$1.44M
-0.03
-94.67%
Salarius Pharmaceuticals
$0.66
$5.23M
-0.02
-97.30%
Scinai Immunotherapeutics
$0.78
$664.23K
-0.07
-75.73%
Dermata Therapeutics
$2.14
$1.87M
-0.10
-84.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
Virax Biolabs Group Ltd. Class A
$0.31
$2.54M
-0.25
-86.97%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NBRVF
Nabriva Therapeutics
0.01
0.00
0.00%
BDRX
Biodexa Pharmaceuticals
2.29
-39.31
-94.50%
SLRX
Salarius Pharmaceuticals
0.77
-37.03
-97.96%
SCNI
Scinai Immunotherapeutics
0.83
-2.61
-75.84%
DRMA
Dermata Therapeutics
2.12
-11.78
-84.75%
VRAX
Virax Biolabs Group Ltd. Class A
0.31
-1.76
-85.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts